Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found ...

Key Takeaways Dormant cancer cells can linger and cause cancer to return years laterA new clinical trial identified and ...

Fifteen-year-old Isabella Harris has a lot going for her. She's a talented dancer and a dedicated student, but right now ...

What if a single test could simultaneously contribute to the diagnosis, characterization, and treatment guidance of childhood ...

The FDA designates ofirnoflast as an orphan drug, highlighting its innovative approach to treating myelodysplastic syndromes ...

THE family of a beloved Carlisle mother of three who 'lived for her family' and inspired many with her brave fight against a rare cancer have ...

First and only therapy FDA approved in both R/R acute myeloid leukemia (AML) with an NPM1 mutation and R/R acute leukemia with a KMT2A translocation - ...

Anti-tumor activity was observed in heavily pretreated mCRPC patients across all dose cohorts; in 22 patients who completed at least 2 cycles of therapy, 59% achieved PSA50 response and 32% achieved P ...

Of the women who Yahoo Canada's menopause survey online, 69 per cent said they felt unprepared for menopause and its impacts.

New findings highlight Telomir-1’s impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways often disrupted in cancer. MIAMI, FLORIDA / ...